PDS Biotechnology Corporation

Rachunek Zysków i Strat





index 0 1 2 3 4 5 6 7 8 9 10 11 12
Rok finansowy 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 0 0 0 0 0 0 0 0 0 0 0 0
Przychód Δ r/r 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Marża brutto -inf% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -inf% -inf% -inf% -inf% -inf% 0.0%
EBIT (mln) -5 -6 -13 -26 -40 -52 -43 -21 -15 -21 -42 -43 -36,321
EBIT Δ r/r 0.0% 38.4% 103.4% 100.8% 49.1% 31.5% -17.1% -51.2% -29.2% 43.9% 94.4% 3.3% 84279.1%
EBIT (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% nan
Koszty finansowe (mln) 0 0 0 1 1 2 1 0 0 0 1 4 -4,673
EBITDA (mln) -5 -6 -13 -28 -39 -51 -29 -17 -15 -21 -41 -43 -36,321
EBITDA(%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% nan
Podatek (mln) 0 -0 -1 -1 -2 -3 -3 -0 0 -5 -1 -1 869
Zysk Netto (mln) -5 -7 -12 -28 -39 -51 -41 -7 -15 -17 -41 -43 -39,349
Zysk netto Δ r/r 0.0% 46.5% 77.3% 130.1% 38.3% 31.0% -19.6% -82.9% 112.1% 13.9% 141.5% 5.1% 91531.8%
Zysk netto (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% nan
EPS -3.3 -9.11 -16.15 -69.43 -26.9 -33.47 -26.16 -1.44 -0.89 -0.66 -1.43 -1.39 -1079.45
EPS (rozwodnione) -3.3 -9.11 -16.15 -69.43 -26.9 -33.47 -26.16 -1.44 -0.89 -0.66 -1.43 -1.39 -1079.45
Ilośc akcji (mln) 1 1 1 0 1 2 2 5 17 26 29 31 36
Ważona ilośc akcji (mln) 1 1 1 0 1 2 2 5 17 26 29 31 36
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD